The company
Founded in 2005, Graftys developed, manufactured and marketed patented resorbable calcium-phosphate cements for reconstructive orthopaedic surgery. These injectable materials harden in the body and are gradually replaced by new bone. Its products were sold in more than 25 countries, including the United States, and in 2022 it acquired Biologics4Life to expand into advanced bone graft materials.
